Sutro Biopharma Stock Quote STRO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.90

Bid

1.84

Ask

1.90

Volume

455

0.00 Day's Range 0.00

1.70 52 Week Range 6.13

Market Cap

156.672M

Previous Close

1.89

Open

Last Trade

1.88

Last Trade Time

08:58:25

Financial Volume

VWAP

Average Volume (3m)

920,562

Shares Outstanding

82,458,725

Dividend Yield

PE Ratio

-1.46

Earnings Per Share (EPS)

-1.3

Revenue

153.73M

Net Profit

-106.79M

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.sutrobio.com

Headquarters

South San Francisco, California, USA

Founded

Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was $1.89. Over the last year, Sutro Biopharma shares have traded in a share price range of $ 1.70 to $ 6.13.

Sutro Biopharma currently has 82,458,725 shares outstanding. The market capitalization of Sutro Biopharma is $155.85 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -1.46.

Form 8-K - Current report

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer

- 32% objective response rate (ORR) in evaluable patients at the 5.2 mg/kg starting dose – the selected dose for randomized portion (Part 2) of ongoing registrational REFRαME-O1 trial - - These...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

- Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials, REFRαME-P1, a registration-enabling...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	1.9	2.005	1.82	639751	1.90958557	CS
4	-0.84	-30.6569343066	2.74	3.01	1.7	1468056	2.28674364	CS
12	-1.69	-47.0752089136	3.59	4.6	1.7	920562	2.75890757	CS
26	-1	-34.4827586207	2.9	5.17	1.7	791599	3.27958826	CS
52	-2.35	-55.2941176471	4.25	6.13	1.7	853330	3.80944135	CS
156	-13.02	-87.2654155496	14.92	15.67	1.7	667591	4.94499092	CS
260	-9.14	-82.7898550725	11.04	28.3	1.7	523040	8.10049862	CS

STRO - Frequently Asked Questions (FAQ)

What is the current Sutro Biopharma share price?

The current share price of Sutro Biopharma is $ 1.90

How many Sutro Biopharma shares are in issue?

Sutro Biopharma has 82,458,725 shares in issue

What is the market cap of Sutro Biopharma?

The market capitalisation of Sutro Biopharma is USD 155.85M

What is the 1 year trading range for Sutro Biopharma share price?

Sutro Biopharma has traded in the range of $ 1.70 to $ 6.13 during the past year

What is the PE ratio of Sutro Biopharma?

The price to earnings ratio of Sutro Biopharma is -1.46

What is the cash to sales ratio of Sutro Biopharma?

The cash to sales ratio of Sutro Biopharma is 1.01

What is the reporting currency for Sutro Biopharma?

Sutro Biopharma reports financial results in USD

What is the latest annual turnover for Sutro Biopharma?

The latest annual turnover of Sutro Biopharma is USD 153.73M

What is the latest annual profit for Sutro Biopharma?

The latest annual profit of Sutro Biopharma is USD -106.79M

What is the registered address of Sutro Biopharma?

The registered address for Sutro Biopharma is 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CALIFORNIA, 94080

What is the Sutro Biopharma website address?

The website address for Sutro Biopharma is www.sutrobio.com

Which industry sector does Sutro Biopharma operate in?

Sutro Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	$ 17.34 (0.00%)	276.91k
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 69.73 (0.00%)	0
AADIAadi Bioscience Inc	$ 3.21 (0.00%)	4.84k
AACGATA Creativity Global	$ 0.762551 (0.00%)	0
AALAmerican Airlines Group Inc	$ 17.34 (0.00%)	282.45k
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 69.73 (0.00%)	0
AADIAadi Bioscience Inc	$ 3.21 (0.00%)	4.84k
AACGATA Creativity Global	$ 0.762551 (0.00%)	0
NXUNXU Inc	$ 0.2434 (0.00%)	125.6M
WATTEnergous Corporation	$ 0.4112 (0.00%)	65.68M
VINCVincerx Inc	$ 0.194 (0.00%)	28.14M
INTZIntrusion Inc	$ 2.16 (0.00%)	27.09M
HOLOMicroCloud Hologram Inc	$ 2.40 (0.00%)	26.76M